GREEN ANALYTICAL CHEMISTRY APPROACH IN RP-HPLC FOR QUANTITATIVE ESTIMATIONS OF TYROSINE KINASE INHIBITOR

Read full text Summarise with VIRAT
Authors: Manish Kumar*, Manish Sharma, Jitendra Banweer
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Tyrosine kinase inhibitors (TKIs) have revolutionized the management of several malignancies by selectively targeting aberrant signaling pathways that drive tumor growth and survival. As their clinical use expands, there is a growing need for robust, sensitive, and environmentally sustainable analytical methods to support quality control, pharmacokinetic monitoring, and regulatory compliance. Reversed‑phase high‑performance liquid chromatography (RP‑HPLC) remains the workhorse technique for quantifying TKIs in pharmaceutical formulations and biological matrices; however, conventional RP‑HPLC methods often rely on toxic organic solvents, high flow rates, and energy‑intensive operations, raising concerns about environmental and occupational safety. In response, the concept of “green RP‑HPLC” has emerged, integrating analytical quality‑by‑design (AQbD), solvent substitution, miniaturization, and multi‑metric greenness assessment into method development workflows. This paper presents a comprehensive account of green RP‑HPLC method development for selected TKIs, illustrated with recent data tables, mechanistic diagrams, and quantitative greenness evaluation using tools such as Analytical Eco‑Scale, AGREE, GAPI, and NEMI.

Fields of Study & Subjects

Analytical Methods in Pharmaceuticals Analytical Chemistry and Chromatography Analytical chemistry methods development

Publication details

Journal / source
Zenodo (CERN European Organization for Nuclear Research)
Publication date
30 March 2026
Language
EN